Grant: Operating Grant
University of British Columbia
$786,560.00
In-vivo analysis of mechanisms of cell death in inherited retinal degeneration
FY 2009-10
Summary
Retinitis pigmentosa (RP) is an inherited disorder in which the light detecting cells of the retina progressively die. Eventually, people with RP may become completely blind.
A key challenge to tackling RP is the diversity of genetic changes that are linked to the disease. Unlike other inherited disorders which are often caused by a single genetic change, RP can result from any one of hundreds of different mutations in several different genes. Does this mean RP is really a hundred different diseases, just one, or several? More specifically, do we need a hundred different treatments for these patients, just one, or several? To answer these questions, we will characterize several strategically chosen genetic mutations that cause different types of retinitis pigmentosa, in order to clarify the mechanisms of disease. These studies will provide valuable information about the progress of retinal degeneration, and help us to better understand how we might design treatments for this disease.
Department
Program
Operating Grant
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
202003
Name
Moritz Orson L
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Cell Biology & Mechanisms of Disease
Projecttitle
In-vivo analysis of mechanisms of cell death in inherited retinal degeneration
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$786,560
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cell Death; Erad; Retinitis Pigmentosa; Rhodopsin; Trafficking; Transgenic Animals
Abstract
Retinitis pigmentosa (RP) is an inherited disorder in which the light detecting cells of the retina progressively die. Eventually, people with RP may become completely blind.
A key challenge to tackling RP is the diversity of genetic changes that are linked to the disease. Unlike other inherited disorders which are often caused by a single genetic change, RP can result from any one of hundreds of different mutations in several different genes. Does this mean RP is really a hundred different diseases, just one, or several? More specifically, do we need a hundred different treatments for these patients, just one, or several? To answer these questions, we will characterize several strategically chosen genetic mutations that cause different types of retinitis pigmentosa, in order to clarify the mechanisms of disease. These studies will provide valuable information about the progress of retinal degeneration, and help us to better understand how we might design treatments for this disease.
Competitiondate
201003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Moritz, Orson L
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $786,560~ $0~